Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

Nicola A Hanania, ATS 2018 – Use of inhaler devices: patient and physician perspectives (Part 1)

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 5th 2018

Nicola A Hanania (Baylor College of Medicine, TX, US) is a valued member of our Editorial Board for US Respiratory & Pulmonary Diseases. He discusses the different types of inhaler systems available for asthma and COPD, recommendations regarding these different delivery platforms and factors to consider when selecting a device for individual patients.

Questions

1. Could you give us a brief overview of the different type of inhaler systems for asthma and COPD? (0:11)
2. Could you tell us a little about the latest guideline recommendations regarding these different delivery platforms? (1:39)
3. What factors should be considered when selecting an inhaler device for a patient with asthma or COPD? (2:39)

View Part 2 here.

View Part 3 here.

Speaker disclosure: Nicola A Hanania has received honoraria for serving on advisory boards or as a consultant for Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, and Sanofi/Regeneron. His institution has received research grant support on his behalf from Boehringer Ingelheim, AstraZeneca, Roche, and GlaxoSmithKline.

 

Filmed at the American Thoracic Society (ATS) International Conference 2018, San Diego, CA, US, May 2018.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup